DCOY

Decoy Therapeutics Inc. Common Stock
DCOY

5 hedge funds and large institutions have $2.01K invested in Decoy Therapeutics Inc. Common Stock in 2025 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 8 closing their positions.

Upgrade to unlock
New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

less ownership

Funds ownership: →

less funds holding

Funds holding: →

less first-time investments, than exits

New positions opened: | Existing positions closed:

98% less capital invested

Capital invested by funds: $104K → $2.01K (-$102K)

Holders
5
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$1.83K
2
+$47
3
+$11
4
DB
Danske Bank
Denmark
+$4

Top Sellers

1
-$28K
2
-$15K
3
-$14.9K
4
Geode Capital Management
Geode Capital Management
Massachusetts
-$13.9K
5
Barclays
Barclays
United Kingdom
-$7K
Name Holding Trade Value Shares
Change 		Change in
Stake
ASN
1
Advisory Services Network
Georgia
$1.83K
UBS Group
2
UBS Group
Switzerland
$106
Osaic Holdings
3
Osaic Holdings
Arizona
$50
Bank of America
4
Bank of America
North Carolina
$15
DB
5
Danske Bank
Denmark
$4
HF
6
HRT Financial
New York
–
CSS
7
Cubist Systematic Strategies
Connecticut
–
Goldman Sachs
8
Goldman Sachs
New York
–
Geode Capital Management
9
Geode Capital Management
Massachusetts
–
Barclays
10
Barclays
United Kingdom
–
Citigroup
11
Citigroup
New York
–
TRCT
12
Tower Research Capital (TRC)
New York
–
MYIA
13
Mount Yale Investment Advisors
Colorado
–
BlackRock
14
BlackRock
New York
–
SS
15
SBI Securities
Japan
–
Morgan Stanley
16
Morgan Stanley
New York
–